Clinical Trials on Adrenal Hyperplasia

Total 15335 results

University of North Carolina, Chapel Hill

Completed

Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

United States
Mansoura University

Completed

A Trial Assessing Peri-procedure Chemoprophylaxis During Transrectal Prostate Needle Biopsy

Benign Prostate Hyperplasia

Egypt
Yuyu Pharma, Inc.

Completed

A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male Subjects

Benign Prostate Hyperplasia
Yonsei University

Completed

Changes of the Hemodynamic Profiles on Bio Reactance Technique During TURP in Elderly Patients

Benign Prostate Hyperplasia
Hanmi Pharmaceutical Company Limited

Completed

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules

Benign Prostatic Hyperplasia
Hanmi Pharmaceutical Company Limited

Completed

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH

Benign Prostate Hyperplasia

Korea, Republic of
IlDong Pharmaceutical Co Ltd

Unknown

Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia

Benign Prostate Hyperplasia

Korea, Republic of
Saskatchewan Health Authority - Regina Area

Completed

Prostatic Artery Embolization for Benign Prostatic Hyperplasia

Benign Prostate Hyperplasia

Canada
Northwestern University
GlaxoSmithKline

Terminated

A Clinical Trial Comparing Laser TURP With and Without Dutasteride.

Benign Prostatic Hyperplasia
American Medical Systems

Completed

A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization (PVP)

Benign Prostatic Hyperplasia

United States
Medifocus, Inc.

Unknown

Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)

Benign Prostate Hyperplasia

United States
Dongkook Pharmaceutical Co., Ltd.

Completed

Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride

Benign Prostate Hyperplasia

Korea, Republic of
Bayer

Completed

Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Germany
Singapore General Hospital

Completed

To Compare Outcomes After Transurethral Enucleation of Prostate Versus Transurethral Resection of Prostate

Benign Prostatic Hyperplasia

Singapore
Fuzhou General Hospital

Completed

Plasmakinetic Enucleation of the Prostate and Open Prostatectomy to Treat Large Prostates

Benign Prostate Hyperplasia

China
Eli Lilly and Company

Completed

Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

Korea, Republic of, Japan
Seoul National University Hospital
GlaxoSmithKline; The Korean Urological Association

Completed

Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate

Benign Prostatic Hyperplasia
Eli Lilly and Company

Completed

A Study in Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States, Italy, Austria
Eli Lilly and Company

Completed

A Study of Tadalafil in Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Germany
Seoul National University Hospital
GlaxoSmithKline; Seoul National University Bundang Hospital

Completed

One-year Prospective Observational Study of BMI Change Effect of 5-alpha Reductase Inhibitor in Korean BPH Patients

Benign Prostatic Hyperplasia

Korea, Republic of
Taipei Medical University WanFang Hospital

Unknown

An Observational Study of Dutasteride and Alpha-blocker Combination Therapy in Men With Symptomatic Benign Prostatic Hyperplasia and PSA Level Over 4 ng/mL

Benign Prostatic Hyperplasia

Taiwan
Eli Lilly and Company

Completed

Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension

Benign Prostatic Hyperplasia

Japan
Eli Lilly and Company

Completed

Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily

Benign Prostatic Hyperplasia

Italy, United States, Germany, Mexico, Argentina
Pnn Medical A/S

Completed

Temperature Mapping of the Prostate With the Wallterm™ System (WT-DK-TMW08)

Benign Prostatic Hyperplasia

Denmark
National Institute of Diabetes and Digestive and...
Merck Sharp & Dohme LLC; Medtronic; Sanofi-Synthelabo; Diagnostic Ultrasound; Uro...

Terminated

Minimally Invasive Surgical Therapy for BPH (MIST)

Benign Prostatic Hyperplasia

United States
National Institute of Diabetes and Digestive and...
National Center for Complementary and Integrative Health (NCCIH)

Completed

Saw Palmetto Extract in Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Eli Lilly and Company
ICOS Corporation

Completed

Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Threshold Pharmaceuticals

Terminated

Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Urologic Consultants of Southeastern PA

Unknown

A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to Avodart

Benign Prostatic Hyperplasia

United States
Indiana Kidney Stone Institute
Lumenis Be Ltd.

Terminated

Holmium Laser Ablation of the Prostate (HoLAP) Versus KTP Laser Vaporization of the Prostate

Benign Prostatic Hyperplasia

United States
Qianfoshan Hospital

Recruiting

A Diagnostic Study of Abnormal Acoustic Waves in Modern Pulse in Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia | Radial Artery

China
Indiana Kidney Stone Institute

Active, not recruiting

Laser Prostatectomy Database and Registry

Benign Prostatic Hyperplasia | Enlarged Prostate

United States
Taipei Veterans General Hospital, Taiwan

Completed

The Effect of Traditional Chinese Medicine on Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Taiwan
University Hospital, Limoges

Terminated

Exploration of Ejaculation Changing Mechanism After Surgery for Benign Prostatic Hyperplasia (EMMECH)

Benign Prostatic Hyperplasia | Ejaculation | Prostate

France
Pierre Fabre Medicament

Completed

Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in Urinary Symptoms Related to BPH (Benign Prostatic Hyperplasia) (PERMIN)

Benign Prostatic Hyperplasia (BPH)

France, Spain, Portugal, Italy
Samsung Medical Center

Completed

Effects of Chronic Use of Doxazosin in Men With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Korea, Republic of
Threshold Pharmaceuticals
PRA Health Sciences

Terminated

Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia | Enlarged Prostate

Hungary, Poland, Germany, Italy
EDAP TMS S.A.

Recruiting

Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound.

Benign Prostatic Hyperplasia

France
TCI Co., Ltd.

Recruiting

The Evaluation of Banana Flower Stamens Extract on Prevention of Benign Prostatic Hyperplasia in Adults

Benign Prostatic Hyperplasia (BPH)

Taiwan
Xiaojun Chen

Completed

MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia

Endometrial Hyperplasia Without Atypia

China
GemVax & Kael

Completed

Evaluate the Efficacy and Safety of GV1001 in Patients With Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia (BPH)

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

An Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia | BPH

Korea, Republic of
Boston Scientific Corporation

Completed

To Evaluate the Feasibility, Preliminary Safety and Performance of Rezūm System in BPH Treatment in China

Benign Prostatic Hyperplasia (BPH)

China
Chinese University of Hong Kong

Terminated

The Use of REZUM System in Chinese Male Patients With LUTS Secondary to Benign Prostate Enlargement

Benign Prostatic Hyperplasia

Hong Kong
Samsung Medical Center

Completed

Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate

Benign Prostatic Hyperplasia (BPH)

Korea, Republic of
PROCEPT BioRobotics

Completed

French Aquablation Clinical Investigation Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue

Benign Prostatic Hyperplasia (BPH)

France
University of Bari
Gaetano de Rienzo; Pasquale Ditonno; Francesco Di Modugno; Michele Battaglia; Giuseppe... and other collaborators

Unknown

Urodynamic Evaluation of Disobstrucitve Power of Aquablation VS Laser Techniques

Benign Prostatic Hyperplasia (BPH)

Italy
UNC Lineberger Comprehensive Cancer Center

Completed

Metformin for the Treatment of Endometrial Hyperplasia

Endometrial Hyperplasia | Endometrial Hyperplasia Without Atypia

United States
University of Helsinki
University of Turku; Oulu University Hospital; Tampere University; South Ostrobothnia...

Completed

KTP (Potassium-titanyl-phosphate) Laser Versus TUR-P (Transurethral Resection of Prostate)

BPH (Benign Prostatic Hyperplasia)

Finland
Pierre Fabre Medicament

Completed

PERmixon® in LUTS Evaluation Study (PERLES) (PERLES)

Benign Prostatic Hyperplasia (BPH)

France, Italy, Germany, Spain, Czech Republic

Clinical Trials on Adrenal Hyperplasia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations